Stay updated on Nivolumab & Brentuximab in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab & Brentuximab in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab & Brentuximab in Lymphoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed. This is a minor version-label update and does not alter page content or functionality.
    Difference
    0.0%
    Check dated 2026-03-12T02:22:43.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Administrative updates show a new site revision (v3.4.2) and removal of the previous funding/operating-status notice; these changes do not affect the study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T14:21:22.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Added a government funding status notice and updated the page to revision 3.4.1, replacing revision 3.4.0.
    Difference
    0.3%
    Check dated 2026-02-04T10:38:29.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated QC labels, including a new 'Revision: v3.4.0'. Removed older QC label variants like 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:30:12.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Site revision updated from v3.3.3 to v3.3.4 (v3.3.3 removed, v3.3.4 added).
    Difference
    0.0%
    Check dated 2026-01-14T03:30:27.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Locations section shows additions and removals of trial sites across the US, Canada, and the UK (e.g., Alabama, Florida, British Columbia, Ontario, Oxfordshire, Surrey). These changes modify the list of active enrollment sites and where eligible participants can join the study.
    Difference
    2%
    Check dated 2025-12-23T20:24:05.000Z thumbnail image

Stay in the know with updates to Nivolumab & Brentuximab in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab & Brentuximab in Lymphoma Clinical Trial page.